Literature DB >> 3978073

Kinetics of the daunomycin--DNA interaction.

J B Chaires, N Dattagupta, D M Crothers.   

Abstract

The kinetics of the interaction of daunomycin with calf thymus DNA are described. Stopped-flow and temperature-jump relaxation methods, using absorption detection, were used to study the binding reaction. Three relaxation times were observed, all of which are concentration dependent, although the two slower relaxations approach constant values at high reactant concentrations. Relaxation times over a wide range of concentrations were gathered, and the data were fit by a minimal mechanism in which a rapid bimolecular association step is followed by two sequential isomerization steps. The six rate constants for this mechanism were extracted from our data by relaxation analysis. The values determined for the six rate constants may be combined to calculate an overall equilibrium constant that is in excellent agreement with that obtained by independent equilibrium measurements. Additional stopped-flow experiments, using first sodium dodecyl sulfate to dissociate bound drug and second pseudo-first-order conditions to study the fast bimolecular step, provide independent verification of three of the six rate constants. The temperature dependence of four of the six rate constants was measured, allowing estimates of the activation energy of some of the steps to be made. We speculate that the three steps in the proposed mechanism may correspond to a rapid "outside" binding of daunomycin to DNA, followed by intercalation of the drug, followed by either conformational adjustment of the drug or DNA binding site or redistribution of bound drug to preferred sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978073     DOI: 10.1021/bi00323a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  DNA repair and personalized breast cancer therapy.

Authors:  Shu-Xia Li; Ashley Sjolund; Lyndsay Harris; Joann B Sweasy
Journal:  Environ Mol Mutagen       Date:  2010 Oct-Dec       Impact factor: 3.216

2.  The anticancer drug-DNA complex: femtosecond primary dynamics for anthracycline antibiotics function.

Authors:  X Qu; C Wan; H C Becker; D Zhong; A H Zewail
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

3.  Fluorinated anthracyclines: interactions with DNA.

Authors:  K C Tonkin; R C Boston; R T Brownlee; D R Phillips
Journal:  Invest New Drugs       Date:  1990-11       Impact factor: 3.850

4.  A pseudocatenane structure formed between DNA and A cyclic bisintercalator.

Authors:  Yongjun Chu; David W Hoffman; Brent L Iverson
Journal:  J Am Chem Soc       Date:  2009-03-18       Impact factor: 15.419

5.  In vitro transcription analysis of the role of flanking sequence on the DNA sequence specificity of adriamycin.

Authors:  H Trist; D R Phillips
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

6.  Cooperative effects on the formation of intercalation sites.

Authors:  Michael Trieb; Christine Rauch; Fajar R Wibowo; Bernd Wellenzohn; Klaus R Liedl
Journal:  Nucleic Acids Res       Date:  2004-09-01       Impact factor: 16.971

7.  Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures.

Authors:  P V Escribá; M Sastre; J A García-Sevilla
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

8.  From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy.

Authors:  Leslie O Ofori; Jason Hoskins; Masayuki Nakamori; Charles A Thornton; Benjamin L Miller
Journal:  Nucleic Acids Res       Date:  2012-04-06       Impact factor: 16.971

9.  A sequence-specific threading tetra-intercalator with an extremely slow dissociation rate constant.

Authors:  Garen G Holman; Maha Zewail-Foote; Amy Rhoden Smith; Kenneth A Johnson; Brent L Iverson
Journal:  Nat Chem       Date:  2011-09-25       Impact factor: 24.427

10.  Mutation induced conformational changes in genomic DNA from cancerous K562 cells influence drug-DNA binding modes.

Authors:  Debjani Ghosh; Subrata Kumar Dey; Chabita Saha
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.